A Randomized, Double-blind, Placebo-controlled, Single/multiple Dosing, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety/tolerability, Pharmacokinetic/pharmacodynamic Characteristics and Food Effect After Oral Administration of IN-114199 in Healthy Participants
Latest Information Update: 25 Dec 2024
Price :
$35 *
At a glance
- Drugs CJ 14199 (Primary)
- Indications Constipation
- Focus Adverse reactions
- Sponsors HK inno.N
- 25 Dec 2024 New trial record